GOLDEN, CO / ACCESSWIRE / Nov. 24, 2021 / Panacea Life Sciences Holdings, Inc. (OTCQB: EXDID), (“Panacea” or the “Company”), a vertically integrated and cGMP certified premium cannabinoid and CBD company, announced today that it will begin trading under the ticker symbol “PLSH” from the opening of the market on Friday, November 26, 2021.
From the Company creation in 2017, Panacea has held to the highest standards for all of its cannabinoid products in several categories, including gummy candies, oil drops, capsules, topicals, skin care, and pet products.
Leslie Buttorff, Founder and CEO of Panacea, said: “The company’s common stock will begin trading under the symbol ‘PLSH’ to reflect our focus on natural health and wellness products as an alternative to prescription drugs. from Big Pharma. In Greek mythology, Panacea is the goddess of universal remedy and “all healing”. With an emphasis on the culture of Everyday Wellness ™ by manufacturing products that use only the highest quality cannabinoids, the Panacea brand embraces its namesake as it continues to build trust and customer base. loyal. “
No action is required from existing Panacea shareholders with respect to the change of stock symbol. The common shares of the Company will continue to be listed on the OTCQB and the CUSIP will remain unchanged.
About Panacea Life Sciences Holdings, Inc.
Panacea Life Sciences Holdings, Inc. is a leader in the production of legal THC-based hemp-derived products for consumers and pets that operates a 51,000 square foot cGMP certified facility in Golden, Colorado and the PANA Farm. Botanicals in Western Colorado, complete with fully integrated extraction, fabrication, testing and execution. Panacea produces capsules, gummies, tinctures, sublingual tablets, cosmetics and other topicals for purchase online ( www.panacealife.com ) and in stores as well as smart kiosk vending machines being rolled out nationwide.
Panacea, which was founded by Leslie Buttorff in 2017 as a woman-owned business, has attracted $ 20 million in initial investment. In 2019, these were followed by a $ 14 million investment from 22nd Century Group, Inc. (XXII), a leading plant biotechnology company focused on technology to reduce nicotine in tobacco plants and uses his expertise in genetic engineering of hemp plants to modify cannabinoids. levels used in the manufacture of CBD, CBG and CBN.
If you would like more information on this topic or to learn more about Panacea and its products or our land-to-brand practices, please visit panacealife.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our Pana product line, including the perceived merits and expected results of our new products, consumer demand and the suitability of our products in retail outlets and in general, and the expected growth of the CBD / hemp industry in which we operate. The words “believe”, “can”, “estimate”, “continue”, “anticipate”, “intend”, “should”, “plan”, “could”, “target”, “potential”, ” it is probable, “” will “,” expect “and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements in large part on our current expectations and projections regarding future events and financial trends that we believe could affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from forward-looking statements include the possibility that our Pana Beauty product line may not be successful due to regulatory challenges and the risk that it is due to sales. insufficient or for other reasons. Other risks are included in filings with the SEC by Panacea Life Sciences Holdings, Inc., parent company of Panacea. Any forward-looking statements we make here speak only as of the date on which they are made. Factors or events that could cause our actual results to vary may occur from time to time, and we cannot predict all of them. We assume no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.
SOURCE: Panacea Life Sciences, Inc
View source version on accesswire.com:
Copyright 2021 ACCESSWIRE. All rights reserved.